Home/Filings/8-K/0001493152-26-000989
8-K//Current report

GENELUX Corp 8-K

Accession 0001493152-26-000989

$GNLXCIK 0001231457operating

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 5:09 PM ET

Size

617.1 KB

Accession

0001493152-26-000989

Research Summary

AI-generated summary of this filing

Updated

GENELUX (GNLX) Announces $20M Underwritten Public Offering

What Happened
GENELUX Corporation (GNLX) announced on January 8, 2026 that it entered into an underwriting agreement with Lucid Capital Markets, LLC to sell an aggregate of 6,666,667 shares of common stock at $3.00 per share in an underwritten public offering. The offering is expected to generate gross proceeds of approximately $20.0 million before underwriting discounts, commissions and estimated expenses, assuming no exercise of the underwriter’s option to purchase additional shares. The company stated the closing is expected to occur on January 9, 2026, subject to customary closing conditions.

Key Details

  • Shares offered: 6,666,667 shares of common stock
  • Price to public: $3.00 per share
  • Estimated gross proceeds: approximately $20.0 million (before fees and expenses)
  • Underwriter: Lucid Capital Markets, LLC; underwriter has an option to purchase additional shares (not assumed exercised)
  • Offering made under the company’s effective Form S-3 shelf registration (File No. 333-276847)
  • Legal opinion from Cooley LLP and related press releases (filed Jan 7 and Jan 8, 2026) are included with the 8-K

Why It Matters
The offering will raise new capital for GENELUX, providing up to about $20.0 million in gross proceeds before expenses. Because the company is issuing new shares, the transaction will increase the number of outstanding shares and thus dilute existing shareholders to some degree. Completion of the offering is subject to customary closing conditions and market risks, so investors should monitor subsequent filings and company announcements for confirmation of closing and any changes to the terms.